{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-046864","form_type":"8-K","ticker":"BIOE","cik":"0001723059","company_name":"Bio Essence Corp","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.234843+00:00","generated_at":"2026-06-14T06:42:10.161016+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bio Essence Corp. converts $2.5M CEO debt into 5M shares","bullets":["Board approved conversion of $2,500,000 debt owed to CEO Yin Yan into 5,000,000 common shares.","Effective May 31, 2023; conversion price $0.50 per share.","Ms. Yan executed a full release of all claims associated with the debt.","Conversion eliminates $2.5M liability from balance sheet, reducing leverage.","Issuance of 5M shares dilutes existing shareholders' equity."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-046864","json":"https://secwatch.observer/filing/0001213900-23-046864.json","markdown":"https://secwatch.observer/filing/0001213900-23-046864.md","text":"https://secwatch.observer/filing/0001213900-23-046864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1723059/000121390023046864/0001213900-23-046864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1723059/000121390023046864/ea179880-8k_bioessence.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:42:10.161016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}